The preformulation investigation of a combination anti-tuberculosis dosage form

Simple item page
dc.contributor.authorEbrahim, Salma
dc.date.accessioned2018-10-10T12:15:54Z
dc.date.available2018-10-10T12:15:54Z
dc.date.issued1998-06-04
dc.descriptionA research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, in partial fulfilment of the requirements for the degree of Master of Science in Medicine (Pharmaceutical affairs) Johannesburg, 1998en_ZA
dc.description.abstractTuberculosis control in South Africa continues to be a major challenge with 90 000 new cases reported in 1995. Major contributory factors towards these epidemic proportions are patient non-compliance and the occurrence of drug resistant tuberculosis. Fixed drug combinations of anti-tuberculosis drugs have been reported to reduce the possibility of resistance arising to any one of the drugs in combination and to improve compliance. However, the combination anti-tuberculosis drugs available at present still suffer the disadvantage of patients having to take 6 tablets per day. Therefore, the purpose of this project was to investigate a formulation that would reduce this disadvantage.en_ZA
dc.description.librarianIT2018en_ZA
dc.identifier.urihttps://hdl.handle.net/10539/25753
dc.language.isoenen_ZA
dc.subject.meshTuberculosis Vaccines
dc.subject.meshSouth Africa
dc.subject.meshIsoniazid
dc.subject.meshPyrazinamide
dc.subject.meshEthambutol
dc.titleThe preformulation investigation of a combination anti-tuberculosis dosage formen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Salma Ebrahim.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
ETD Collection